Eliem Therapeutics, Inc. (ELYM)
USD 5.11
(-0.97%)
USD 5.11
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -20.59 Million | -37.36 Million | -36.07 Million | -14.09 Million | -5 Million |
| Net Income | -35.11 Million | -45.24 Million | -47.48 Million | -20.66 Million | -6.54 Million |
| Depreciation & Amortization | - | - | 1.84 Million | - | - |
| Deferred income taxes | - | -1.39 Million | -1.84 Million | - | - |
| Stock-based compensation | 12.8 Million | 6.99 Million | 3.73 Million | 707 Thousand | - |
| Change in working capital | 3.76 Million | 210 Thousand | -4.17 Million | -2.93 Million | -309 Thousand |
| Other non-cash items | -2.05 Million | 2.06 Million | 11.84 Million | 8.79 Million | 1.84 Million |
| Investing Cash Flow | 68.98 Million | 34.44 Million | -114.97 Million | 8.07 Million | - |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | 8279.00 | - |
| Investment purchases | -58.44 Million | -87.96 Million | -114.97 Million | - | - |
| Sales/Maturities of investments | 127.43 Million | 122.4 Million | - | - | - |
| Other Investing Activities | 68.98 Thousand | 34.44 Thousand | -114.97 Thousand | 8.06 Million | - |
| Financing Cash Flow | 841 Thousand | - | 177.23 Million | 4.92 Million | 26.24 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 841 Thousand | - | 83.14 Million | 4.92 Million | 26.24 Million |
| Other Financing Activities | 841 Thousand | - | 94.08 Million | 4925.00 | 26.24 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -686 Thousand | -653 Thousand | 150 Thousand | -24 Thousand | 17 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 4.45 Million | 863 Thousand | -4.32 Million | -2.91 Million | -326 Thousand |
| Cash at beginning of period | 43.58 Million | 46.92 Million | 20.48 Million | 21.22 Million | - |
| Cash at end of period | 93.11 Million | 43.58 Million | 46.92 Million | 20.48 Million | 21.22 Million |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | 304 Thousand | -408 Thousand | 245 Thousand | 359 Thousand | -12 Thousand |
| Net cash flow / Change in cash | 49.52 Million | -3.33 Million | 26.43 Million | -736 Thousand | 21.22 Million |
| Free Cash Flow | -20.59 Million | -37.36 Million | -36.07 Million | -14.09 Million | -5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -54.88 Million | -1.69 Million | -3.64 Million | -35.11 Million | -3.96 Million | -5.22 Million |
| Depreciation & Amortization | - | -63 Thousand | 491 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 512 Thousand | 465 Thousand | 1.2 Million | 12.8 Million | 656 Thousand | 777 Thousand |
| Change in working capital | 1.98 Million | -640 Thousand | 1.42 Million | 3.76 Million | 7.47 Million | -2.67 Million |
| Other non-cash items | 52.24 Million | 518 Thousand | 71 Thousand | -2.05 Million | -671 Thousand | -850 Thousand |
| Investing Cash Flow | -9.64 Million | 13.75 Million | 36.74 Million | 68.98 Million | 28.03 Million | -1.6 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -4.64 Million | - | - | - | - | - |
| Investment purchases | - | - | -1000.00 | -58.44 Million | -2.46 Million | -38.53 Million |
| Sales/Maturities of investments | - | 13.75 Million | 36.74 Million | 127.43 Million | 30.5 Million | 36.93 Million |
| Other Investing Activities | -5 Million | 13.75 Million | 36.74 Thousand | 68.98 Thousand | 28.03 Thousand | -1601.00 |
| Financing Cash Flow | 128.4 Million | 15 Thousand | 288 Thousand | 841 Thousand | 528 Thousand | 24 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 128.4 Million | 15 Thousand | 288 Thousand | 841 Thousand | 528 Thousand | 24 Thousand |
| Other Financing Activities | - | 15 Thousand | 288.00 | 841 Thousand | 528.00 | 24.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.17 Million | 20 Thousand | -672 Thousand | -686 Thousand | -142 Thousand | 14 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.98 Million | -640 Thousand | 2.09 Million | 4.45 Million | 7.61 Million | -2.68 Million |
| Cash at beginning of period | 105.03 Million | 93.11 Million | 57.35 Million | 43.58 Million | 25.29 Million | 34.43 Million |
| Cash at end of period | 223.14 Million | 105.03 Million | 93.11 Million | 93.11 Million | 57.35 Million | 25.29 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 19 Thousand | -28 Thousand | -330 Thousand | 304 Thousand | 4000.00 | 399 Thousand |
| Net cash flow / Change in cash | 118.1 Million | 11.91 Million | 35.75 Million | 49.52 Million | 32.05 Million | -9.14 Million |
| Free Cash Flow | -667 Thousand | -1.81 Million | -947 Thousand | -20.59 Million | 3.49 Million | -7.96 Million |
PHIL
5574
KESORAMIND
WELPP
MASI
CENTEXT